Viyash Scientific Limited Schedules Board Meeting on May 19, 2026 to Approve Q4 FY26 Financial Results

Viyash Scientific Limited (formerly known as Sequent Scientific Limited) has notified the stock exchanges of an upcoming Board of Directors meeting, scheduled for Tuesday, May 19, 2026. The intimation was filed pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was communicated via a letter dated May 12, 2026, signed by Company Secretary & Compliance Officer Yoshita Vora.

Board Meeting Agenda

The Board meeting has been convened to address key financial and shareholder matters for the period ended March 31, 2026. The following items are on the agenda:

Agenda Item:	Details
Financial Results:	Consider and approve Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026
Dividend Recommendation:	Recommend dividend, if any, on equity shares for the year ended March 31, 2026
Meeting Date:	Tuesday, May 19, 2026

Trading Window Closure

In continuation of the company's earlier intimation dated March 30, 2026, and in accordance with the Company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their Immediate Relatives, the trading window for dealing in the securities of Viyash Scientific remains closed. The closure is effective from April 01, 2026, and will continue until 48 hours after the announcement of financial results, i.e., up to May 21, 2026.

The filing was made from the company's registered office located at 3rd Floor, Srivalli's Corporate, Plot No. 290, Road No. 6, Sy. No. 33, 34P to 39, Guttala Begumpet, Jubilee Hills, Hyderabad, Shaikpet, Telangana, India - 500033.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.97%	+3.70%	+10.98%	-0.01%	+35.97%	-11.21%

Viyash Scientific Limited has completed the allotment of 8,000 equity shares under its Employee Stock Option Plan 2020 to eligible employees. The Nomination and Remuneration Committee approved this allotment through a resolution passed by circulation on April 28, 2026.

ESOP Allotment Details

The company allotted the equity shares at a predetermined exercise price, providing employees with an opportunity to acquire company ownership. The allotment represents the exercise of stock options granted under the SeQuent ESOP 2020 scheme.

Parameter:	Details
Number of Shares Allotted:	8,000 equity shares
Face Value per Share:	Rs. 2
Exercise Price:	Rs. 86 per equity share
Allotment Date:	April 28, 2026
ESOP Scheme:	SeQuent ESOP 2020

Impact on Share Capital

The allotment has resulted in an increase in the company's issued and paid-up equity share capital. The newly allotted shares will carry the same rights and privileges as existing equity shares of the company.

Capital Structure:	Before Allotment	After Allotment
Paid-up Capital:	Rs. 87,37,34,954	Rs. 87,37,50,954
Number of Shares:	43,68,67,477	43,68,75,477
Face Value:	Rs. 2 each	Rs. 2 each

Share Rights and Ranking

The newly allotted equity shares will rank pari passu in all respects with the existing equity shares of the company. This means the new shares will have equal rights regarding dividends, voting, and other corporate benefits.

Corporate Compliance

Viyash Scientific Limited, formerly known as Sequent Scientific Limited, has duly informed the stock exchanges about this allotment in compliance with regulatory requirements. The company secretary and compliance officer has signed the disclosure, ensuring proper adherence to corporate governance norms.